ESCMID COVID-19 guidelines: diagnostic testing for SARS-CoV-2
- 23 February 2022
- journal article
- research article
- Published by Elsevier BV in Clinical Microbiology & Infection
- Vol. 28 (6), 812-822
- https://doi.org/10.1016/j.cmi.2022.02.011
Abstract
No abstract availableThis publication has 110 references indexed in Scilit:
- Saliva as an Alternate Specimen Source for Detection of SARS-CoV-2 in Symptomatic Patients Using Cepheid Xpert Xpress SARS-CoV-2Journal of Clinical Microbiology, 2020
- Clinical Evaluation of Three Sample-to-Answer Platforms for Detection of SARS-CoV-2Journal of Clinical Microbiology, 2020
- Comparison of Abbott ID Now and Abbott m2000 Methods for the Detection of SARS-CoV-2 from Nasopharyngeal and Nasal Swabs from Symptomatic PatientsJournal of Clinical Microbiology, 2020
- Spread of SARS-CoV-2 in the Icelandic PopulationThe New England Journal of Medicine, 2020
- Saliva sample as a non-invasive specimen for the diagnosis of coronavirus disease 2019: a cross-sectional studyClinical Microbiology & Infection, 2020
- Prevalence of SARS-CoV-2 infection in previously undiagnosed health care workers at the onset of the U.S. COVID-19 epidemicPublished by Cold Spring Harbor Laboratory ,2020
- Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in ChinaJAMA, 2020
- Evidence of SARS-CoV-2 Infection in Returning Travelers from Wuhan, ChinaThe New England Journal of Medicine, 2020
- Comparison of Two Methods to Detect Publication Bias in Meta-analysisJAMA, 2006
- A comparison of methods to detect publication bias in meta‐analysisStatistics in Medicine, 2001